XML 168 R60.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details) - USD ($) $ in Thousands |  | 1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Nov. 07, 2023 | Nov. 07, 2023 | Sep. 30, 2024 | Jan. 31, 2024 | Sep. 30, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2024 | Sep. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022
Balance |  |  |  |  | $ (13,442) | $ (19,187) | $ (15,701) | $ (13,442) | $ (39,055) | $ (31,899) | $ (26,359) |  | $ (13,442) | $ (26,359) |  | $ (26,359) |  | $ (7,052) |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 8 |
Exercise of stock options, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 613,510,000 |  | 6,648,000 |
Issuance of Series A-2 Preferred Stock |  |  |  |  | $ 200 |  |  | 242 |  |  |  |  |  |  |  | $ 16 |  |  |
Issuance of Series A-2 Preferred Stock. shares |  | 20,000,000 | 543,057 |  | 277,778 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  | 4,285 | 2,165 | 1,935 |  |  |  |  | 9,207 |  | $ 8,073 |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 47,936 |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (11,937) |  |  |
Stock-based compensation expense |  |  |  |  |  | 207 | 103 | 137 | 798 | 280 | 368 |  |  |  |  | 1,475 |  | 1,865 |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,198 |
Net loss |  |  |  |  |  | (2,058) | (3,589) | (2,109) | (13,840) | (9,601) | (7,843) |  | (7,755) | (31,284) |  | (33,780) | [1] | (30,451) | [2]
Balance |  |  |  | $ (14,268) |  | (14,268) | (19,187) | (15,701) | (47,796) | (39,055) | (31,899) |  | (14,268) | (47,796) |  | (13,442) |  | (26,359) |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | $ 2 | $ 2 | $ 2 | $ 2 |  |  |  |  | $ 2 |  |  |  |  |  |
Balance, shares |  |  |  |  | 23,572,232 | 24,050,010 | 23,850,010 | 23,572,232 | 4,210,445 | 4,033,170 | 4,033,170 |  | 23,572,232 | 4,033,170 |  | 4,033,170 |  | 4,342,666 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retroactive application of recapitalization due to Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (493,420) |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services, shares |  |  |  |  |  |  |  |  | 88,638 | 177,275 |  |  |  |  |  | 265,914 |  | 177,276 |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 543,056 |  | 6,648 |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock. shares |  |  |  | 526,312 |  |  |  | 277,778 |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,420,945 |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1 |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,261,553 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,475,362 |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,572,232 |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  | $ 2 |  | $ 2 | $ 2 | $ 2 |  |  |  |  | $ 2 |  |  | $ 2 |  |  |
Balance, shares |  | 6,261,553 | 6,261,553 | 28,175,172 |  | 28,175,172 | 24,050,010 | 23,850,010 | 4,299,083 | 4,210,445 | 4,033,170 |  | 28,175,172 | 4,299,083 |  | 23,572,232 |  | 4,033,170 |
Additional Paid-in Capital [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | $ 77,996 | $ 78,478 | $ 78,375 | $ 77,996 | $ 18,405 | $ 15,960 | $ 13,657 |  | $ 77,996 | $ 13,657 |  | $ 13,657 |  | $ 2,513 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8 |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  | 242 |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  | 4,285 | 2,165 | 1,935 |  |  |  |  | 9,207 |  | 8,073 |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,659 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 47,935 |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (11,937) |  |  |
Stock-based compensation expense |  |  |  |  |  | 207 | 103 | 137 | 798 | 280 | 368 |  |  |  |  | 1,475 |  | 1,865 |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,198 |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  | $ 85,455 |  | 85,455 | 78,478 | 78,375 | 23,488 | 18,405 | 15,960 |  | 85,455 | 23,488 |  | 77,996 |  | 13,657 |
Retained Earnings [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | (91,440) | (97,138) | (93,549) | (91,440) | (75,104) | (65,503) | (57,660) |  | (91,440) | (57,660) |  | (57,660) |  | (27,209) |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  | (2,058) | (3,589) | (2,109) | (13,840) | (9,601) | (7,843) |  |  |  |  | (33,780) |  | (30,451) |
Balance |  |  |  | (99,196) |  | (99,196) | (97,138) | (93,549) | (88,944) | (75,104) | (65,503) |  | (99,196) | (88,944) |  | (91,440) |  | (57,660) |
Temporary Equity [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  | 17,644 | 17,644 | 17,644 |  |  | 17,644 |  | 17,644 |  | 17,644 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16 |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (17,660) |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  | 17,660 | 17,644 | 17,644 |  |  | 17,660 |  |  |  | 17,644 |
Temporary Equity [Member] | Series A-2 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  | $ 9,634 | $ 9,634 | $ 9,634 |  |  | $ 9,634 |  | $ 9,634 |  | $ 9,634 |
Balance, shares |  |  |  |  |  |  |  |  | 3,415,923 | 3,415,923 | 3,415,923 |  |  | 3,415,923 |  | 3,415,923 |  | 3,853,797 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retroactive application of recapitalization due to Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (437,874) |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 16 |  |  |
Issuance of Series A-2 Preferred Stock. shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,673 |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (9,650) |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,421,596) |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  | $ 9,650 | $ 9,634 | $ 9,634 |  |  | $ 9,650 |  |  |  | $ 9,634 |
Balance, shares |  |  |  |  |  |  |  |  | 3,421,596 | 3,415,923 | 3,415,923 |  |  | 3,421,596 |  |  |  | 3,415,923 |
Temporary Equity [Member] | Series A-1 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  | $ 8,010 | $ 8,010 | $ 8,010 |  |  | $ 8,010 |  | $ 8,010 |  | $ 8,010 |
Balance, shares |  |  |  |  |  |  |  |  | 2,839,957 | 2,839,957 | 2,839,957 |  |  | 2,839,957 |  | 2,839,957 |  | 3,204,000 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retroactive application of recapitalization due to Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (364,043) |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (8,010) |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2,839,957) |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  | $ 8,010 | $ 8,010 | $ 8,010 |  |  | $ 8,010 |  |  |  | $ 8,010 |
Balance, shares |  |  |  |  |  |  |  |  | 2,839,957 | 2,839,957 | 2,839,957 |  |  | 2,839,957 |  |  |  | 2,839,957 |
Previously Reported [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | $ (12,859) |  |  | (12,859) |  |  | $ 9,273 |  | (12,859) | $ 9,273 |  | $ 9,273 |  | $ 14,438 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (534) |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200 |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7 |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN stock options upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 613 |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,859 |  |  |
Conversion of OMN convertible loans upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,178 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,058 |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2,257) |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 101 |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 746 |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (28,750) |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,893 |  | 1,392 |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11,633 |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (23,206) | [1] | (6,230) | [2]
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (12,859) |  | 9,273 |
Previously Reported [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | $ 3 |  |  | $ 3 |  |  | $ 1 |  | $ 3 | $ 1 |  | $ 1 |  | $ 1 |
Balance, shares |  |  |  |  | 23,572,232 |  |  | 23,572,232 |  |  | 9,388,958 |  | 23,572,232 | 9,388,958 |  | 9,388,958 |  | 7,802,941 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retroactive application of recapitalization due to Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,378,517 |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [3] | 200,000 |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,500 |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock. shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN stock options upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN stock options upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 612,670 |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,859,464 |  |  |
Conversion of OMN convertible loans upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1 |  |  |
Conversion of OMN convertible loans upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,177,229 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,057,797 |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private OneMedNet to ONMD Public Shares, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2,257,326) |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1,266,560) |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3 |  | $ 1 |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 23,572,232 |  | 9,388,958 |
Previously Reported [Member] | Commitment [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ 28,750 |  |  | $ 28,750 |  | $ 28,750 |  | $ 28,750 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN stock options upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible loans upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (28,750) |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 28,750 |
Previously Reported [Member] | Additional Paid-in Capital [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | 42,221 |  |  | 42,221 |  |  | 24,032 |  | 42,221 | 24,032 |  | 24,032 |  | 19,607 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,826 |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200 |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7 |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN stock options upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 613 |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,859 |  |  |
Conversion of OMN convertible loans upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,177 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,057 |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2,257) |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 101 |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 746 |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,893 |  | 1,392 |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 42,221 |  | 24,032 |
Previously Reported [Member] | Retained Earnings [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | (55,083) |  |  | (55,083) |  |  | (43,510) |  | (55,083) | (43,510) |  | (43,510) |  | (33,920) |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,360) |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN stock options upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible loans upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11,633 |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (23,206) |  | (6,230) |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (55,083) |  | (43,510) |
Previously Reported [Member] | Temporary Equity [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Previously Reported [Member] | Temporary Equity [Member] | Series A-2 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  | 3,853,797 |  |  | 3,853,797 |  | 3,853,797 |  | 3,853,797 |
Conversion of OMN convertible promissory notes upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,853,797) |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,853,797 |
Previously Reported [Member] | Temporary Equity [Member] | Series A-1 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  | 3,204,000 |  |  | 3,204,000 |  | 3,204,000 |  | 3,204,000 |
Conversion of OMN convertible promissory notes upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,204,000) |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,204,000 |
Revision of Prior Period, Reclassification, Adjustment [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | $ (583) |  |  | $ (583) |  |  | $ (35,632) | [4] | $ (583) | $ (35,632) | [4] | $ (35,632) | [4] | $ (21,490) | [5]
Retroactive application of recapitalization due to Business Combination | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 534 |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [3] | (200) | [6]
Exercise of stock options | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |
Issuance of Series A-2 Preferred Stock | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16 |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 9,207 | [7] | 8,073 | [8]
Exercise of OMN stock options upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (613) |  |  |
Exercise of OMN warrants upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,859) |  |  |
Conversion of preferred stock to common stock upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (7,058) |  |  |
Conversion of OMN convertible promissory notes upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 41,758 |  |  |
Private OneMedNet to ONMD Public Shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,257 |  |  |
Issuance of PIPE warrants | [7] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (101) |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (12,683) |  |  |
Common stock redemption | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 28,750 |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (418) | [10] | 473 | [11]
Retained earnings adjustment | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (11,633) |  |  |
Issuance of OMN warrants to board of directors | [12] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,198 |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (10,574) | [1],[13] | (24,221) | [2],[14]
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (583) |  | (35,632) | [4]
Revision of Prior Period, Reclassification, Adjustment [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | $ (1) |  |  | $ (1) |  |  | $ (1) | [4] | $ (1) | $ (1) | [4] | $ (1) | [4] | $ (1) | [5]
Balance, shares |  |  |  |  |  |  |  |  |  |  | (5,355,788) | [4] |  | (5,355,788) | [4] | (5,355,788) | [4] | (3,460,275) | [5]
Retroactive application of recapitalization due to Business Combination | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retroactive application of recapitalization due to Business Combination, shares | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1,871,937) |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [3] |  | [6]
Issuance of common shares in exchange for services, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 265,914 | [3] | (22,724) | [6]
Exercise of stock options | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options, shares | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (852) |
Issuance of Series A-2 Preferred Stock | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [7] |  | [8]
Exercise of OMN stock options upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN stock options upon Business Combination, shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (69,614) |  |  |
Exercise of OMN warrants upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination, shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (438,519) |  |  |
Conversion of preferred stock to common stock upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (796,244) |  |  |
Conversion of OMN convertible promissory notes upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible promissory notes upon Business Combination, shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (701,867) |  |  |
Private OneMedNet to ONMD Public Shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private OneMedNet to ONMD Public Shares, shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,257,326 |  |  |
Issuance of PIPE warrants | [7] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,838,792 |  |  |
Common stock redemption | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [10] |  | [11]
Retained earnings adjustment | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors | [12] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [13] |  | [14]
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (1) |  | $ (1) | [4]
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (5,355,788) | [4]
Revision of Prior Period, Reclassification, Adjustment [Member] | Commitment [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ (28,750) | [4] |  | $ (28,750) | [4] | $ (28,750) | [4] | $ (28,750) | [5]
Retroactive application of recapitalization due to Business Combination | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [3] |  | [6]
Exercise of stock options | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [7] |  | [8]
Exercise of OMN stock options upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible promissory notes upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private OneMedNet to ONMD Public Shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants | [7] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock redemption | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 28,750 |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [10] |  | [11]
Retained earnings adjustment | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors | [12] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [13] |  | [14]
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (28,750) | [4]
Revision of Prior Period, Reclassification, Adjustment [Member] | Additional Paid-in Capital [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | 35,775 |  |  | 35,775 |  |  | (10,375) | [4] | 35,775 | (10,375) | [4] | (10,375) | [4] | (17,094) | [5]
Retroactive application of recapitalization due to Business Combination | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2,826) |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [3] | (200) | [6]
Exercise of stock options | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |
Issuance of Series A-2 Preferred Stock | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 9,207 | [7] | 8,073 | [8]
Exercise of OMN stock options upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (613) |  |  |
Exercise of OMN warrants upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,859) |  |  |
Conversion of preferred stock to common stock upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10,602 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 41,758 |  |  |
Private OneMedNet to ONMD Public Shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,257 |  |  |
Issuance of PIPE warrants | [7] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (101) |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (12,683) |  |  |
Common stock redemption | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (418) | [10] | 473 | [11]
Retained earnings adjustment | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors | [12] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,198 |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [13] |  | [14]
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 35,775 |  | (10,375) | [4]
Revision of Prior Period, Reclassification, Adjustment [Member] | Retained Earnings [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | (36,357) |  |  | (36,357) |  |  | (14,150) | [4] | (36,357) | (14,150) | [4] | (14,150) | [4] | 6,711 | [5]
Retroactive application of recapitalization due to Business Combination | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,360 |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [3] |  | [6]
Exercise of stock options | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [7] |  | [8]
Exercise of OMN stock options upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible promissory notes upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private OneMedNet to ONMD Public Shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants | [7] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock redemption | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | [10] |  | [11]
Retained earnings adjustment | [4] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (11,633) |  |  |
Issuance of OMN warrants to board of directors | [12] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (10,574) | [13] | (24,221) | [14]
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (36,357) |  | (14,150) | [4]
Revision of Prior Period, Reclassification, Adjustment [Member] | Temporary Equity [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | 17,644 | [4] |  | 17,644 | [4] | 17,644 | [4] | 17,644 | [5]
Issuance of Series A-2 Preferred Stock | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16 |  |  |
Conversion of preferred stock to common stock upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (17,660) |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,644 | [4]
Revision of Prior Period, Reclassification, Adjustment [Member] | Temporary Equity [Member] | Series A-2 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ 9,634 | [4] |  | $ 9,634 | [4] | $ 9,634 | [4] | $ 9,634 | [5]
Balance, shares |  |  |  |  |  |  |  |  |  |  | (437,874) | [4] |  | (437,874) | [4] | (437,874) | [4] |  | [5]
Retroactive application of recapitalization due to Business Combination, shares | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (437,874) |
Issuance of Series A-2 Preferred Stock | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 16 |  |  |
Issuance of Series A-2 Preferred Stock. shares | [3] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,673 |  |  |
Conversion of preferred stock to common stock upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (9,650) |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 432,201 |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 9,634 | [4]
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (437,874) | [4]
Revision of Prior Period, Reclassification, Adjustment [Member] | Temporary Equity [Member] | Series A-1 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ 8,010 | [4] |  | $ 8,010 | [4] | $ 8,010 | [4] | $ 8,010 | [5]
Balance, shares |  |  |  |  |  |  |  |  |  |  | (364,043) | [4] |  | (364,043) | [4] | (364,043) | [4] |  | [5]
Retroactive application of recapitalization due to Business Combination, shares | [6] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (364,043) |
Conversion of preferred stock to common stock upon Business Combination | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (8,010) |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares | [9] |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 364,043 |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 8,010 | [4]
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (364,043) | [4]
Restated [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | $ (13,442) |  |  | $ (13,442) |  |  | $ (26,359) |  | $ (13,442) | $ (26,359) |  | $ (26,359) |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16 |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 9,207 |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 47,936 |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (11,937) |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,475 |  |  |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (33,780) |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (13,442) |  | $ (26,359) |
Restated [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | $ 2 |  |  | $ 2 |  |  |  |  | $ 2 |  |  |  |  |  |
Balance, shares |  |  |  |  | 23,572,232 |  |  | 23,572,232 |  |  | 4,033,170 |  | 23,572,232 | 4,033,170 |  | 4,033,170 |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 265,914 |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 543,056 |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,420,945 |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1 |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,261,553 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,475,362 |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,572,232 |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2 |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 23,572,232 |  | 4,033,170 |
Restated [Member] | Commitment [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restated [Member] | Additional Paid-in Capital [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | 77,996 |  |  | 77,996 |  |  | 13,657 |  | 77,996 | 13,657 |  | 13,657 |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 9,207 |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,659 |  |  |
Conversion of OMN convertible promissory notes upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 47,935 |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (11,937) |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,475 |  |  |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 77,996 |  | 13,657 |
Restated [Member] | Retained Earnings [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  | (91,440) |  |  | (91,440) |  |  | (57,660) |  | (91,440) | (57,660) |  | (57,660) |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants in conjunction with convertible promissory notes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of OMN warrants upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private OneMedNet to ONMD Public Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of PIPE warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock redemption |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retained earnings adjustment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (33,780) |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (91,440) |  | (57,660) |
Restated [Member] | Temporary Equity [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | 17,644 |  |  | 17,644 |  | 17,644 |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16 |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (17,660) |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,644 |
Restated [Member] | Temporary Equity [Member] | Series A-2 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ 9,634 |  |  | $ 9,634 |  | $ 9,634 |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  | 3,415,923 |  |  | 3,415,923 |  | 3,415,923 |  |  |
Issuance of Series A-2 Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 16 |  |  |
Issuance of Series A-2 Preferred Stock. shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,673 |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (9,650) |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (3,421,596) |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 9,634 |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,415,923 |
Restated [Member] | Temporary Equity [Member] | Series A-1 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ 8,010 |  |  | $ 8,010 |  | $ 8,010 |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  | 2,839,957 |  |  | 2,839,957 |  | 2,839,957 |  |  |
Conversion of preferred stock to common stock upon Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ (8,010) |  |  |
Conversion of preferred stock to common stock upon Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2,839,957) |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 8,010 |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,839,957 |
As Restated [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ (26,359) |  |  | $ (26,359) |  | $ (26,359) |  | $ (7,052) |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8 |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,865 |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,198 |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (30,451) |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (26,359) |
As Restated [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  | 4,033,170 |  |  | 4,033,170 |  | 4,033,170 |  | 4,342,666 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retroactive application of recapitalization due to Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (493,420) |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 177,276 |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,648 |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,033,170 |
As Restated [Member] | Commitment [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
As Restated [Member] | Additional Paid-in Capital [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | 13,657 |  |  | 13,657 |  | 13,657 |  | 2,513 |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8 |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,865 |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,198 |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 13,657 |
As Restated [Member] | Retained Earnings [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | (57,660) |  |  | (57,660) |  | (57,660) |  | (27,209) |
Retroactive application of recapitalization due to Business Combination |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common shares in exchange for services |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise of stock options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of OMN warrants to board of directors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (30,451) |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (57,660) |
As Restated [Member] | Temporary Equity [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | 17,644 |  |  | 17,644 |  | 17,644 |  | 17,644 |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17,644 |
As Restated [Member] | Temporary Equity [Member] | Series A-2 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ 9,634 |  |  | $ 9,634 |  | $ 9,634 |  | $ 9,634 |
Balance, shares |  |  |  |  |  |  |  |  |  |  | 3,415,923 |  |  | 3,415,923 |  | 3,415,923 |  | 3,853,797 |
Retroactive application of recapitalization due to Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (437,874) |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 9,634 |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,415,923 |
As Restated [Member] | Temporary Equity [Member] | Series A-1 Preferred Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance |  |  |  |  |  |  |  |  |  |  | $ 8,010 |  |  | $ 8,010 |  | $ 8,010 |  | $ 8,010 |
Balance, shares |  |  |  |  |  |  |  |  |  |  | 2,839,957 |  |  | 2,839,957 |  | 2,839,957 |  | 3,204,000 |
Retroactive application of recapitalization due to Business Combination, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (364,043) |
Balance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 8,010 |
Balance, shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,839,957 |
[1] | Accumulated effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.
[2] | Accumulated effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.
[3] | Impact of errors related to the accounting and presentation of the recapitalization.
[4] | Cumulative impact of corrections of errors to the prior year.
[5] | Cumulative impact of corrections of errors to the prior year.
[6] | Impact of errors related to the accounting and presentation of the recapitalization.
[7] | Impact of errors related to identification, classification and valuation of equity-classified warrants.
[8] | Impact of errors related to identification, classification and valuation of equity-classified warrants.
[9] | Includes impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial statements.
[10] | Impact of errors related to improper valuation of stock compensation expense.
[11] | Impact of errors related to improper valuation of stock compensation expense.
[12] | Impact of error related to identificatoin and recognition of board of director warrante expense.
[13] | Current year impact of corrections of errors to the consolidated statements of operations.
[14] | Current year impact of corrections of errors to the consolidated statements of operations.

X
- Definition Common stock subject to possible redemption value. + References No definition available. + Details
Name: | ONMD_CommonStockSubjectToPossibleRedemptionValue
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Retroactive application of recapitalization due to business combination shares. + References No definition available. + Details
Name: | ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
Namespace Prefix: | ONMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock issued during period shares conversion of convertible loans upon business combination. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock issued during period shares conversion of preferred stock to common stock upon business combination. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock issued during period shares stock options exercised upon business combination. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock issued during period shares stock options upon business combination with net of liabilities assumed and transaction costs. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
Namespace Prefix: | ONMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodSharesWarrantsExercised
Namespace Prefix: | ONMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock issued during period value conversion of convertible loans upon business combination. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock issued during period value conversion of convertible promissory notes upon business combination. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock issued during period value issuance of warrants to board of directors. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock issued during period value retained earnings adjustment. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock issued during period value stock options exercised upon business combination. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Stock issued during period value stock options upon business combination with net of liabilities assumed and transaction costs. + References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | ONMD_StockIssuedDuringPeriodValueWarrantsExercised
Namespace Prefix: | ONMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12 + Details
Name: | us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 25 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2 + Details
Name: | us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issued which are neither cancelled nor held in the treasury. + References No definition available. + Details
Name: | us-gaap_SharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of preferred stock and warrants for common stock issued. + References No definition available. + Details
Name: | us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of stock issued attributable to transactions classified as other. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of share options (or share units) exercised during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodValueIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Value of shares of stock issued attributable to transactions classified as other. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodValueOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Value of stock issued as a result of the exercise of stock options. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(19)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2 + Details
Name: | us-gaap_StockholdersEquity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ONMD_TemporaryEquityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=ONMD_CommitmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RestatementAxis=ONMD_RestatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RestatementAxis=ONMD_AsRestatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |